Chief Executive Officer
Fredrik Hultenius

Fredrik has been part of QPharma since 2021, initially leading Production and Site Operations in Malmö before advancing to Vice President of Operations with global responsibilities. In 2025, he was appointed Chief Executive Officer. Prior to joining QPharma, Fredrik held a series of operational and leadership roles within Baxter International, gaining extensive experience in pharmaceutical and medical device manufacturing. His expertise spans operational excellence, manufacturing operations, organizational development, and leadership in highly regulated manufacturing environments. Fredrik holds an M.Sc. in Production Engineering from Charlmers University of Technology and a B.Sc. in Mechanical Engineering from Jönköping University.

Chief Financial Officer
Niklas Ellerström

Niclas joined QPharma in 2024 as Head of Finance and was appointed Chief Financial Officer in 2026. Before joining QPharma, Niclas held senior finance and business controlling positions within international companies in the pharmaceutical, food, and logistics industries, including Findus, FedEx Express, and DHL Express. He brings extensive experience in financial management, business planning, forecasting, and performance analysis across global organizations. Niclas holds a B.Sc. in Business Administration from Lund University.

Chief Science Officer
Wouter De Graaff

Wouter is a seasoned expert in controlled release drug delivery and inventor of more than 15 patents related to controlled release formulations. Before joining QPharma in 2015, he headed the pharmaceutical development of polymer-based delivery systems within MSD (Merck) and the legacy companies Schering Plough and Organon. At QPharma, he is responsible for Research and Development, including Regulatory Affairs. Wouter graduated from the University of Amsterdam and holds an M.Sc. in Chemical Engineering.

Vice President Business Development and Marketing
Ulrike Foley

Ulrike “Uli” Foley joined QPharma as Head of Global Business Development & Marketing in 2025. She brings more than 30 years of experience in business development within the pharmaceutical industry and the CDMO sector. Before joining QPharma, Uli most recently served as Vice President of Business Development at Adare/Frontida Biopharm. Throughout her career, she has built extensive expertise in business development, strategic partnerships, and supporting pharmaceutical companies through all stages of drug product development. Ulrike has a BS in International Business from Golden Gate University, San Francisco, CA and a Masters in Public Heath/Health Economics from University of North Carolina, Chapel Hill.

Global Head of HR
Stefan Peterson

Stefan joined QPharma as Global Human Resource Director in 2024. He brings extensive international leadership experience from several industries, most recently as Vice President Human Resources for Business Area Life Science at Getinge, an international group offering hospitals and life science institutions advanced technological solutions. Before that, he held senior HR and communication roles at ONE Nordic, and his career also includes international HR positions at Carlsberg and E.ON. Stefan holds a Bachelor of Science in Human Resources from Lund University, Sweden.

Vice President Operations
Linda Rebert

Linda has been part of QPharma since 2020, initially leading the QC department before taking responsibility for Engineering and Operational Excellence. In 2025, she was appointed Vice President of Operations. Before joining QPharma, Linda held management positions at Chr. Hansen and Polypeptide, where she gained extensive experience in the bioscience and pharmaceutical industries. Her experience spans quality, engineering, and operational excellence, with a strong focus on driving performance and continuous improvement. Linda holds an B.Sc. in Chemical Engineering from Lund University and is a certified Lean Six Sigma Black Belt.

Vice President Quality
Niklas Lindgren

Niklas joined QPharma as Vice President of Quality in 2026. He brings more than three decades of experience in quality management, regulatory compliance, and manufacturing operations within the pharmaceutical and medical device industries. Before joining QPharma, Niklas served as Vice President QA/RA and Operations at Dignitana. Prior to that, he spent more than 20 years at Baxter International, where he held several senior leadership positions, including Site Manager QA for the Lund facility and Quality Management Representative. Throughout his career, he has built extensive expertise in quality systems and regulatory compliance within highly regulated global environments.

Global Director Project Management Office
Marie Svensson

Marie has been part of QPharma since 2007 and has held several roles within engineering, project management, and leadership. In 2025, she was appointed Global Director PMO, responsible for the global Project Management Office, project governance, and project portfolio management across Sweden and the U.S. Throughout her career at QPharma, Marie has built extensive experience in project management, pharmaceutical product development, business development, and resource planning. Marie holds a Master of Science in Bioengineering from Chalmers University of Technology.

General Manager US
James Turner

James joined Foster Delivery Science in 2022 as Director of Quality and Regulatory Compliance. He was appointed to head the site in Putnam, CT USA at the beginning of 2026. James has 20+ years of experience in the pharmaceutical business ranging from formulation development to quality control to quality assurance to safety. His background ensures that new products at the Putnam site are developed with quality in mind.  James holds a B.A. in Chemistry from the University of Connecticut.